AZD6234
A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234
AstraZeneca · Phase 1 · Not yet recruiting · Enrollment 60
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Regimen A | Healthy Participants | n/r | n/r | n/r | n/r |
| Regimen B | Healthy Participants | n/r | n/r | n/r | n/r |
| Regimen C | Healthy Participants | n/r | n/r | n/r | n/r |
| Regimen D | Healthy Participants | n/r | n/r | n/r | n/r |
| Regimen E | Healthy Participants | n/r | n/r | n/r | n/r |